Literature DB >> 26773263

A combined TD-DFT and spectroscopic investigation of the solute-solvent interactions of efavirenz.

Maryam A Jordaan1, Parvesh Singh2, Bice S Martincigh2.   

Abstract

Efavirenz, commercially known as Sustiva® or Stocrin®, is a first-line antiretroviral treatment for HIV/AIDS. The clinical efficacy of efavirenz is, however, hindered by its solubility. We sought to investigate the solute-solvent effects of efavirenz by means of a combined qualitative study implementing UV-visible spectrophotometry, (1)H NMR spectroscopy and time-dependent density functional theory (TD-DFT) calculations. The UV spectrum displayed two main absorbance maxima, band I and band II at 246-260 and 291-295 nm, respectively. A general bathochromic shift was noticed from the non-polar solvent cyclohexane to the most polar solvent DMSO (≈13.69 nm) in band I and a smaller bathochromic (≈2.17 nm) and hyperchromic shift was observed in band II. We propose that these observations are due to the role of the amino (NH) and carbonyl (CO) functionalities which induce charge-transfer and intra- and inter-molecular hydrogen bonding. The aromatic and amine protons showed the most deshielded effects in the observed chemical shifts (δ) in the more polar DMSO-d6 solvent relative to CDCl3. The (1)H NMR chemical shifts observed are due to the increased delocalization of the lone pair electrons of the amino nitrogen with increased polarity of the more polar DMSO solvent. The theoretical reproduction of the UV and (1)H NMR spectra by means of TD-DFT is in good agreement with the experimental results.
Copyright © 2015. Published by Elsevier B.V.

Entities:  

Keywords:  (1)H NMR spectroscopy; Efavirenz; Hydrogen bonding; Polarity; TD-DFT calculations; UV–visible spectrophotometry

Mesh:

Substances:

Year:  2015        PMID: 26773263     DOI: 10.1016/j.saa.2015.12.008

Source DB:  PubMed          Journal:  Spectrochim Acta A Mol Biomol Spectrosc        ISSN: 1386-1425            Impact factor:   4.098


  1 in total

1.  Investigation of the solvent-dependent photolysis of a nonnucleoside reverse-transcriptase inhibitor, antiviral agent efavirenz.

Authors:  Maryam A Jordaan; Michael Shapi
Journal:  Antivir Chem Chemother       Date:  2017-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.